Original price was: ৳ 2,650.00.৳ 2,350.00Current price is: ৳ 2,350.00.
The Ordinary Glycolic Acid 7% Toning Solution – 240ml
The Ordinary Glycolic Acid 7% Toner exfoliates, brightens, and smooths skin texture, revealing a fresher, more radiant complexion.
Glycolic Acid Toner – The Ordinary 7% Toning Solution 240ml
The Glycolic Acid Toner from The Ordinary is a gentle chemical exfoliating toner formulated with 7% glycolic acid. It helps remove dead skin cells, brighten dull skin, and smooth uneven texture, revealing a more radiant complexion.
Discover more The Ordinary skincare products or learn about glycolic acid benefits.
Main Benefits of This Toner
- Gently exfoliates without over-drying
- Brightens skin and evens tone
- Improves texture and smoothness
- Minimizes pore appearance
- Boosts skin radiance over time
Why Choose This Exfoliating Toner
This glycolic acid 7% exfoliant is enriched with aloe vera, ginseng, and Tasmanian pepperberry to soothe skin while reducing irritation from exfoliation. Suitable for most skin types except very sensitive skin.
How to Use
- Apply in the evening after cleansing.
- Use a cotton pad to sweep across face and neck.
- Avoid eye area.
- Follow with a hydrating serum and moisturizer.
- Wear SPF the next day.
Who Should Use It
- Those with dull, uneven skin tone
- People with rough texture or visible pores
- Not recommended for highly sensitive skin
Key Ingredients
- Glycolic Acid (7%) – Smooths and resurfaces skin
- Aloe Vera – Hydrates and soothes
- Ginseng Root Extract – Boosts radiance
- Tasmanian Pepperberry – Helps reduce irritation
Pro Tips
- Start 2–3 times per week, increase if tolerated
- Pair with sunscreen daily
Frequently Asked Questions
Q: Can I use this toner every day?
A: Start gradually to build tolerance and avoid irritation.
Q: Can I use this with retinol?
A: Alternate nights are best to prevent over-exfoliation.
Q: Is it good for acne-prone skin?
A: Yes, it helps unclog pores and improve skin clarity.
Brand | The Ordinary |
---|
Reviews
There are no reviews yet.